ATE291468T1 - Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern - Google Patents

Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern

Info

Publication number: ATE291468T1
Authority: AT; Austria
Prior art keywords: huperzine; prevention; treatment; children; hyperactivity
Prior art date: 2001-04-23

Application number

AT01961133T

Other languages

English (en)

Inventor

Franco Gaetani

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-23

Filing date

2001-08-03

Publication date

2005-04-15

2001-08-03 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2005-04-15 Application granted granted Critical

2005-04-15 Publication of ATE291468T1 publication Critical patent/ATE291468T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
230000002265 prevention Effects 0.000 title abstract 2
PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
ZQPQGKQTIZYFEF-WCVJEAGWSA-N Huperzine Natural products C1([C@H]2[C@H](O)C(=O)N[C@H]2[C@@H](O)C=2C=CC=CC=2)=CC=CC=C1 ZQPQGKQTIZYFEF-WCVJEAGWSA-N 0.000 title 1
229960004203 carnitine Drugs 0.000 title 1
230000007812 deficiency Effects 0.000 title 1
208000013403 hyperactivity Diseases 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
UBAPRWGDQPSCEH-UHFFFAOYSA-N Des-N-methyl-beta-obscurine Natural products N1CCCC2C3CC(C)CC21C(C=CC(=O)N1)=C1C3 UBAPRWGDQPSCEH-UHFFFAOYSA-N 0.000 abstract 1
241001090156 Huperzia serrata Species 0.000 abstract 1
ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 abstract 1
YYWGABLTRMRUIT-XHBSWPGZSA-N Huperzine B Natural products N1CCC[C@@H]2[C@@H]3C=C(C)C[C@]21C(C=CC(=O)N1)=C1C3 YYWGABLTRMRUIT-XHBSWPGZSA-N 0.000 abstract 1
208000020358 Learning disease Diseases 0.000 abstract 1
RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 abstract 1
230000006735 deficit Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000284 extract Substances 0.000 abstract 1
235000013402 health food Nutrition 0.000 abstract 1
ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 abstract 1
201000003723 learning disability Diseases 0.000 abstract 1
ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

AT01961133T 2001-04-23 2001-08-03 Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern ATE291468T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2001RM000218A ITRM20010218A1 (it)	2001-04-23	2001-04-23	Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi
PCT/IT2001/000430 WO2002085341A2 (en)	2001-04-23	2001-08-03	Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder

Publications (1)

Publication Number	Publication Date
ATE291468T1 true ATE291468T1 (de)	2005-04-15

Family

ID=11455486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01961133T ATE291468T1 (de)	2001-04-23	2001-08-03	Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern

Country Status (12)

Country	Link
US (1)	US20040058947A1 (de)
EP (1)	EP1383579B1 (de)
AT (1)	ATE291468T1 (de)
CA (1)	CA2436240A1 (de)
DE (1)	DE60109651T2 (de)
ES (1)	ES2237591T3 (de)
HU (1)	HUP0303963A3 (de)
IT (1)	ITRM20010218A1 (de)
MX (1)	MXPA03009631A (de)
PL (1)	PL367613A1 (de)
PT (1)	PT1383579E (de)
WO (1)	WO2002085341A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2390055B (en)	2002-03-22	2005-09-07	Cypher Science Internat Ltd	A marking apparatus
CN100441200C (zh) *	2004-11-26	2008-12-10	谢德隆	石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法
GB201205856D0 (en) *	2012-04-02	2012-05-16	Randall Jeremy A P	Food supplement to support brain function
CN102702101B (zh) *	2012-05-23	2016-04-06	长沙市惠瑞生物科技有限公司	一种从千层塔中提取石杉碱甲的方法
CN103667072B (zh) *	2013-09-27	2016-04-13	浙江工业大学	一种蛇足石杉内生真菌及其在制备8α,15α-环氧化石杉碱甲的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2288990A1 (en) *	1997-04-29	1998-11-05	Kenneth Blum, Inc.	Allelic polygene diagnosis of reward deficiency syndrome and treatment
US5869528A (en) *	1997-07-22	1999-02-09	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Therapeutical method for the treatment of attention-deficit/hyperactive disorders
US6964969B2 (en) *	2001-04-19	2005-11-15	Mccleary Edward Larry	Composition and method for treating impaired or deteriorating neurological function

2001
- 2001-04-23 IT IT2001RM000218A patent/ITRM20010218A1/it unknown
- 2001-08-03 PT PT01961133T patent/PT1383579E/pt unknown
- 2001-08-03 ES ES01961133T patent/ES2237591T3/es not_active Expired - Lifetime
- 2001-08-03 DE DE60109651T patent/DE60109651T2/de not_active Expired - Fee Related
- 2001-08-03 PL PL01367613A patent/PL367613A1/xx unknown
- 2001-08-03 AT AT01961133T patent/ATE291468T1/de not_active IP Right Cessation
- 2001-08-03 MX MXPA03009631A patent/MXPA03009631A/es unknown
- 2001-08-03 US US10/250,359 patent/US20040058947A1/en not_active Abandoned
- 2001-08-03 EP EP01961133A patent/EP1383579B1/de not_active Expired - Lifetime
- 2001-08-03 CA CA002436240A patent/CA2436240A1/en not_active Abandoned
- 2001-08-03 HU HU0303963A patent/HUP0303963A3/hu unknown
- 2001-08-03 WO PCT/IT2001/000430 patent/WO2002085341A2/en not_active Ceased

Also Published As

Publication number	Publication date
PL367613A1 (en)	2005-03-07
DE60109651T2 (de)	2006-04-27
ES2237591T3 (es)	2005-08-01
WO2002085341A3 (en)	2003-05-08
ITRM20010218A1 (it)	2002-10-23
EP1383579B1 (de)	2005-03-23
MXPA03009631A (es)	2004-06-30
CA2436240A1 (en)	2002-10-31
HUP0303963A2 (hu)	2004-04-28
US20040058947A1 (en)	2004-03-25
ITRM20010218A0 (it)	2001-04-23
EP1383579A2 (de)	2004-01-28
HUP0303963A3 (en)	2005-04-28
WO2002085341A2 (en)	2002-10-31
DE60109651D1 (de)	2005-04-28
PT1383579E (pt)	2005-06-30

Similar Documents

Publication	Publication Date	Title
DE60313597D1 (de)	2007-06-14	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ATE319453T1 (de)	2006-03-15	Reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
ATE265857T1 (de)	2004-05-15	Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
PT1347971E (pt)	2006-06-30	Inibidores tiazolilicos de tirosina-cinases da familia tec
ATE494275T1 (de)	2011-01-15	Herstellung von cis-pellitorin und verwendung als aromastoff
ATE281085T1 (de)	2004-11-15	Nahrungsergänzung zur behandlung von makula degeneration
ATE286028T1 (de)	2005-01-15	Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
ATE508114T1 (de)	2011-05-15	Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
DE60323765D1 (de)	2008-11-06	Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
DE60318839D1 (de)	2008-03-13	2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
DE60115872D1 (de)	2006-01-19	Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom
ATE459353T1 (de)	2010-03-15	Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
ATE417607T1 (de)	2009-01-15	Sphingolipide gegen krankhafte prozesse in lipid rafts
ATE406884T1 (de)	2008-09-15	Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
ATE237341T1 (de)	2003-05-15	Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l- carnitin derivate und ginkgo biloba extrakte
ATE424825T1 (de)	2009-03-15	Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
DE60206289D1 (de)	2006-02-02	Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
ATE291468T1 (de)	2005-04-15	Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
ATE397453T1 (de)	2008-06-15	Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
DE60200476D1 (de)	2004-06-17	Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
ATE317849T1 (de)	2006-03-15	5-hydroxysapogenin derivate mit aktivität gegen demenz
DE69832722D1 (de)	2006-01-12	L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
DE60333742D1 (de)	2010-09-23	Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia
DE60107900D1 (de)	2005-01-27	Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
BRPI0410026A (pt)	2006-04-25	derivados de 3-amino-croman quinolina

Legal Events

Date

Code

Title

Description

2005-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1383579

Country of ref document: EP

2006-11-15

REN

Ceased due to non-payment of the annual fee